Gilead Sciences, Inc. (GILD)
NASDAQ: GILD · IEX Real-Time Price · USD
67.40
-0.32 (-0.47%)
May 20, 2024, 9:34 AM EDT - Market open
Gilead Sciences Stock Forecast
Stock Price Forecast
The 15 analysts with 12-month price forecasts for Gilead Sciences stock have an average target of 84, with a low estimate of 69 and a high estimate of 105. The average target predicts an increase of 24.63% from the current stock price of 67.40.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for GILD stock from 16 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 2 | 2 | 3 | 3 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 7 | 6 | 7 | 7 | 10 | 10 |
| Sell | 1 | 1 | 1 | 1 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 13 | 13 | 13 | 16 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Hold Maintains $80 → $76 | Hold | Maintains | $80 → $76 | +12.76% | Apr 29, 2024 |
| TD Cowen | TD Cowen | Strong Buy Maintains $90 → $85 | Strong Buy | Maintains | $90 → $85 | +26.11% | Apr 26, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $80 → $78 | Hold | Maintains | $80 → $78 | +15.73% | Apr 26, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $76 → $74 | Hold | Maintains | $76 → $74 | +9.79% | Apr 26, 2024 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Apr 26, 2024 |
Financial Forecast
Revenue This Year
28.04B
from 27.12B
Increased by 3.42%
Revenue Next Year
28.60B
from 28.04B
Increased by 1.98%
EPS This Year
7.24
from 4.50
Increased by 60.98%
EPS Next Year
7.58
from 7.24
Increased by 4.58%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 29.4B | 30.7B | 31.9B | 33.1B | 36.4B |
| Avg | 28.0B | 28.6B | 29.5B | 30.1B | 31.3B |
| Low | 26.5B | 26.7B | 26.9B | 26.6B | 27.2B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 8.5% | 9.4% | 11.7% | 12.2% | 20.7% |
| Avg | 3.4% | 2.0% | 3.0% | 2.2% | 3.8% |
| Low | -2.1% | -4.8% | -6.1% | -9.9% | -9.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 8.40 | 8.66 | 9.07 | 9.66 | 10.40 |
| Avg | 7.24 | 7.58 | 7.94 | 7.99 | 8.57 |
| Low | 6.71 | 6.48 | 6.69 | 6.55 | 6.94 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 86.7% | 19.6% | 19.7% | 21.6% | 30.2% |
| Avg | 61.0% | 4.6% | 4.8% | 0.5% | 7.3% |
| Low | 49.2% | -10.6% | -11.7% | -17.6% | -13.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.